152 results
Page 2 of 8
8-K
EX-99.1
6q1bf dhzynwrr7pnxen
1 Aug 23
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
4:10pm
8-K
ip4a4h80l7pur1aco0s
7 Jul 23
Departure of Directors or Certain Officers
4:37pm
8-K
EX-99.1
8z6w uvr67l5gy3z9
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
S-8
bqyiy
21 Apr 23
Registration of securities for employees
4:36pm
8-K
EX-99.1
xuowlmbh03
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
fi4h6tw
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
61png9r2b21iglm
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
3w2 guhpd7p6b
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
y2oyd89fbc wajr86
4 May 22
Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
uaam236
23 Feb 22
Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance
12:00am
8-K
EX-99.1
rs5tp
10 Jan 22
Nevro Announces Preliminary, Unaudited Fourth Quarter and Fourth Quarter 2021 Worldwide Revenue of Approximately $102.5 Million
6:12am